Dual biomarker strategy

Cross-source consensus on Dual biomarker strategy from 1 sources and 5 claims.

1 sources · 5 claims

Uses

Systematic perioperative testing with both hs-cTnI and NT-proBNP can identify higher-risk patients after elective thoracic lung resection. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study
The biomarker combination is useful because RCRI had limited discriminatory value in this cohort. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study
Serial preoperative and postoperative dual biomarker measurements allowed detection of both myocardial injury and sustained cardiac stress. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study
The dual-biomarker approach may support closer monitoring, cardiology involvement, and refined postoperative follow-up. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study
Serial biomarker testing was characterized as objective, readily available, inexpensive, relatively cost-effective, and less resource-intensive than more complex monitoring. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study